CAPTRUST FINANCIAL ADVISORS - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$262,935
-19.9%
1,555
+2.7%
0.00%0.0%
Q2 2023$328,311
+3183.1%
1,514
+1746.3%
0.00%
Q2 2022$10,000
+900.0%
82
+720.0%
0.00%
Q1 2022$1,0000.0%10
+11.1%
0.00%
Q4 2021$1,0000.0%9
+12.5%
0.00%
Q3 2021$1,0000.0%80.0%0.00%
Q2 2021$1,0000.0%8
+60.0%
0.00%
Q1 2021$1,00050.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,912,872$369,323,00052.78%
Pivotal bioVenture Partners Investment Advisor LLC 852,708$108,115,00051.15%
Sofinnova Investments, Inc. 1,953,077$247,631,00018.79%
Nan Fung Group Holdings Ltd 234,811$29,772,00014.12%
Sands Capital Ventures, LLC 267,895$33,966,0007.10%
Logos Global Management LP 340,000$43,109,0005.59%
DAFNA Capital Management LLC 82,053$10,403,0002.71%
Ghost Tree Capital, LLC 60,000$7,607,0001.65%
CATALYST PRIVATE WEALTH, LLC 24,976$3,167,0001.58%
Eventide Asset Management 748,000$94,839,0001.49%
View complete list of KARUNA THERAPEUTICS INC shareholders